window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Global health

  • Artificial Intelligence,Biotech,Clinical Development,Diagnostics,Digital Health,Drug Development,Global health,Healthcare leadership,Precision medicine,Women's Health

    Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction

    Clairity, an AI-driven precision health company, has raised $43 million [...]

    November 13, 2025
  • Biotech,European biotech,Events and Conferences,Global health,Market Access & Commercialization,Partnerships & Funding

    Switzerland showcases collaborative life science ecosystem at Nordic Life Science Days 2025

    Switzerland used Nordic Life Science Days 2025 to make a [...]

    October 21, 2025
  • Global health,Healthcare leadership,Women in Pharma

    Pioneering consultant Dr Rageshri Dhairyawan wins 2025 Gilead & Kite campaigner for health equity award

    NHS consultant and author Dr Rageshri Dhairyawan has been awarded [...]

    October 12, 2025
  • European biotech,Events and Conferences,Global health,Healthcare leadership,Market Access & Commercialization,Partnerships & Funding,Research & Development

    Nordic Life Science Days 2025 opens in Gothenburg with calls for deeper collaboration and global investment

    The Nordic Life Science Days 2025 opened today (October 13) [...]

    October 13, 2025
  • Biologics & Biosimilars,Clinical Development,European biotech,Global health,Hematology,Rare Diseases,Technology and platforms

    Terumo BCT and Hemex Health join forces to improve outcomes for sickle cell patients

    Terumo Blood and Cell Technologies (Terumo BCT), a global medical [...]

    October 10, 2025
  • Digital Health,Global health,Market Access & Commercialization,Movers & Shakers,Patient Centricity,Pharmaceuticals and therapeutics,Technology and platforms

    HeliosX strengthens leadership team to drive global growth and brand innovation

    HeliosX has expanded its senior leadership team with the appointments [...]

    October 2, 2025
  • Biotech,Clinical Development,Clinical Trials,Drug Development,Global health,Partnerships & Funding,Rare Diseases,Research & Development

    SeaBeLife secures €2 million to advance dual-targeted therapies for dry AMD and severe acute hepatitis

    SeaBeLife, a biotechnology company developing novel drug candidates to block [...]

    October 1, 2025
  • Artificial Intelligence,Clinical Trials,Digital Health,Drug Development,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    QuantHealth secures strategic investment from Sanofi Ventures to accelerate AI-driven clinical trials

    QuantHealth, a pioneer in AI-driven clinical trial simulation, has received [...]

    October 1, 2025
  • Digital Health,Global health,Market Access & Commercialization,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    M42 partners with Medical Tourism Association and Mastercard to expand UAE’s global patient reach

    M42, a global health leader leveraging artificial intelligence, technology, and [...]

    October 1, 2025
  • Biologics & Biosimilars,Clinical Development,Clinical studies,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    PACE launches third funding round to tackle antimicrobial resistance and support innovative therapeutics

    PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its third [...]

    October 1, 2025
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top